| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $374.8M | — | +15.6% |
| Cost of Revenue | $121.3M | — | +12.1% |
| Gross Profit | $253.4M | — | +17.4% |
| R&D Expense | $22.4M | — | +1.4% |
| SG&A Expense | $192.8M | — | +25.6% |
| Operating Income | $38.2M | — | -5.2% |
| Pre-tax Income | $41.7M | — | -4.9% |
| Income Tax | $9.1M | — | +96.4% |
| Net Income | $32.6M | — | -16.9% |
| EPS (Basic) | $0.83 | — | -18.6% |
| EPS (Diluted) | $0.82 | — | -18.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $241.3M | +29.1% | -35.8% |
| Accounts Receivable | $183.3M | -3.5% | +9.1% |
| Inventory | $438.5M | +1.6% | +5.5% |
| Current Assets | $1.28B | +4.8% | +27.6% |
| Total Assets | $1.90B | +3.9% | +19.2% |
| Current Liabilities | $211.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $87.0M | — | +77.6% |
| Capital Expenditures | $13.7M | — | +1.5% |
| Investing Cash Flow | -$30.6M | — | -6002.2% |
| Financing Cash Flow | -$1.9M | — | -170.4% |
| Free Cash Flow | $73.3M | — | +106.5% |
| +33.5% |
| Total Liabilities | $424.6M | +6.4% | +11.6% |
| Stockholders' Equity | $1.47B | +3.2% | +21.5% |